Browsing Sydney Pharmacy School by publication year
-
(4,7-Dimethyl-1,10-phenanthroline (ethylenediamine) platinum(II) dichloride tris(deuterium oxide) solvate
Published 2006-01-01Open AccessArticle -
Novel platinum(II)-based anticancer complexes and molecular hosts as their drug delivery vehicles
Published 2007-01-01Open AccessArticle -
Diffusion-based studies on the self-stacking and nanorod formation of platinum(II) intercalators
Published 2009-01-01Open AccessArticle -
A chemical preformulation study of a host–guest complex of cucurbit[7]uril and a multinuclear platinum agent for enhanced anticancer drug delivery
Published 2009-01-01Single crystal and powder X-ray diffraction have been used to examine the host–guest complex of cucurbit[7]uril (CB[7]) and the model dinuclear platinum anticancer complex trans-[{PtCl(NH3)2}2μ-dpzm]2+ (di-Pt, dpzm= ...Open AccessArticle -
The status of platinum anticancer drugs in the clinic and in clinical trials
Published 2010-01-01Since its approval in 1979 cisplatin has become an important component in chemotherapy regimes for the treatment of ovarian, testicular, lung and bladder cancers, as well as lymphomas, myelomas and melanoma. Unfortunately ...Open AccessArticle -
INCREASING PATIENT DEMAND FOR HOME MEDICINES REVIEWS: A MARKETING PLAN
Published 2010-02-01Campbell (2008)stated that “Consumer awareness of the program is of major concern” and concluded that “all stakeholders agreed that the Home Medicines Review (HMR) Program should be promoted more to consumers and carers.” ...Open AccessConference poster -
INCREASING PATIENT DEMAND FOR HOME MEDICINES REVIEWS: A MARKETING PLAN RESEARCH STUDY
Published 2010-02-01Objectives: 1. To deliver a marketing plan which proposes strategies to increase consumer uptake of HMRs. Sub -objectives were to assess the: Awareness levels of eligible non-recipients prior to participation in this ...Open AccessConference poster -
The status of platinum anticancer drugs in the clinic and in clinical trials
Published 2010-06-30Since its approval in 1979 cisplatin has become an important component in chemotherapy regimes for the treatment of ovarian, testicular, lung and bladder cancers, as well as lymphomas, myelomas and melanoma. Unfortunately ...Open AccessArticle -
Improving the Uptake of the Australian Home Medicines Review through Patient Segmentation
Published 2011-01-01The Australian Home Medicines Review (HMR) Program, aimed at reducing the number of medication-related problems and hospital admissions, has not been used to the extent projected and is little known among eligible consumers. ...Open AccessArticle -
Evaluation of anionic half generation 3.5–6.5 poly(amidoamine) dendrimers as delivery vehicles for the active component of the anticancer drug cisplatin
Published 2011-05-27Aquated cisplatin was added to half-generation PAMAM dendrimers and the resultant complexes were purified by centrifuge. The drug–dendrimer complexes were then characterised by 1-D and diffusion 1H NMR and ICP-AES. The ...Open AccessArticle -
Rationalising sequence selection by ligand assemblies in the DNA minor groove: the case for thiazotropsin A
Published 2011-12-15DNA-sequence and structure dependence on the formation of minor groove complexes at 50-XCYRGZ-30, where Y ¼ T and R ¼ A, by the short lexitropsin thiazotropsin A are explored based on NMR spectroscopy, isothermal titration ...Open AccessArticle -
Consumer Perspectives of the Australian Home Medicines Review Program: Benefits and Barriers
Published 2012-01-01BACKGROUND: The Australian Home Medicines Review (HMR) is a free consumer service to assist individuals living at home to maximize the benefits of their medicine regimen and prevent medication related problems. It consists ...Open AccessArticle -
Elderly Chinese and Vietnamese Immigrants’ Medicine Use and Attitudes to a Home Medicines Review
Published 2012-01-01There is a paucity of research into the perceptions of elderly Australian ethnic minorities towards public health services related to quality use of medicines. Among the six fastest growing ethnic groups in Australia, the ...Open AccessArticle -
Service Quality in Community Pharmacy: an Exploration of Determinants
Published 2012-01-01BACKGROUND: Although various instruments have been developed to measure customer satisfaction with community pharmacy services, there is limited research regarding pharmacy staffs’ understanding of service quality and its ...Open AccessArticle -
Nanoparticles: the future for platinum drugs or a research red herring?
Published 2012-01-01Open AccessArticle -
Cisplatin-Tethered Gold Nanoparticles That Exhibit Enhanced Reproducibility, Drug Loading, and Stability: a Step Closer to Pharmaceutical Approval?
Published 2012-03-05Gold nanoparticles (AuNPs) can be used as delivery vehicles for platinum anticancer drugs, improving their targeting and uptake into cells. Here, we examine the appropriateness of different-sized AuNPs as components of ...Open AccessArticle -
NON-ADHERENCE TO PATIENT SAFETY GUIDELINES: AN EVOLUTIONARY, ECOLOGICAL HYPOTHESIS
Published 2012-04-16Often well meaning health care workers do not adhere to patient safety guidelines or recommendations, with serious consequences; patient injuries and mortality. Non-adherence has been attributed to external limitations, ...Open AccessArticle -
Cucurbit[7]uril encapsulated cisplatin overcomes cisplatin resistance via a pharmacokinetic effect
Published 2012-04-18The cucurbit[n]uril (CB[n]) family of macrocycles has been shown to have potential in drug delivery where they are able to provide physical and chemical stability to drugs, improve drug solubility, control drug release and ...Open AccessArticle -
Folding of dinuclear platinum anticancer complexes within the cavity of para-sulphonatocalix[4]arene
Published 2012-05-03The binding of three dinuclear platinum complexes, where the bridging ligand of the complexes is N,N0- (alkane-1,n-diyl)diisonicotinamide (n = 4, 6 or 8 for butane, hexane and octane, respectively) to the macrocycle ...Open AccessArticle